TOLERO PHARMACEUTICALS, INC.
21Patents
21Active
21Granted
52Portfolio score
Filing activity: Jul 21, 2011 → Oct 28, 2019
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9758539B2 | Alvocidib prodrugs having increased bioavailability | Chemistry; Metallurgy | 22 | Active |
| US9394257B2 | PKM2 modulators and methods for their use | Chemistry; Metallurgy | 19 | Active |
| US9901574B2 | Predicting response to alvocidib by mitochondrial profiling | Physics | 17 | Active |
| US10259835B2 | Alvocidib prodrugs having increased bioavailability | Chemistry; Metallurgy | 16 | Active |
| US10132797B2 | Profiling peptides and methods for sensitivity profiling | Physics | 13 | Active |
| US10267787B2 | Profiling peptides and methods for sensitivity profiling | Physics | 13 | Active |
| US10422788B2 | Profiling peptides and methods for sensitivity profiling | Physics | 11 | Active |
| US10357488B2 | Predicting response to alvocidib by mitochondrial profiling | Physics | 11 | Active |
| US9493454B2 | Multiple kinase pathway inhibitors | Human Necessities | 10 | Active |
| US10202356B2 | JAK2 and ALK2 inhibitors and methods for their use | Chemistry; Metallurgy | 9 | Active |
| US10568887B2 | Combination therapies for treatment of cancer | Human Necessities | 9 | Active |
| US10562925B2 | Alvocidib prodrugs having increased bioavailability | Chemistry; Metallurgy | 8 | Active |
| US10624880B2 | Predicting response to alvocidib by mitochondrial profiling | Physics | 7 | Active |
| US10682356B2 | Combination therapies for treatment of cancer | Human Necessities | 7 | Active |
| US9714247B2 | Multiple kinase pathway inhibitors | Human Necessities | 6 | Active |
| US8710057B2 | Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives and their use as protein kinase inhibitors | Human Necessities | 5 | Active |
| US9416132B2 | Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10047093B2 | Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10207996B2 | PKM2 modulators and methods for their use | Chemistry; Metallurgy | 2 | Active |
| US10472328B2 | PKM2 modulators and methods for their use | Chemistry; Metallurgy | 2 | Active |
| US10392392B2 | Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.